Login / Signup

Prevalence and mortality of ceftazidime/avibactam-resistant KPC-producing Klebsiella pneumoniae bloodstream infections (2018-2022).

Matteo BoattiniGabriele BiancoPaulo BastosSara CominiSilvia CorcioneAndré AlmeidaCristina CostaFrancesco Giuseppe De RosaRossana Cavallo
Published in: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology (2023)
Ceftazidime/avibactam resistance in KPC-Kp BSI easily emerged in our highly KPC-Kp endemic area with remarkable mortality rates. Our findings might provide physicians possibly actionable information when managing patients with a ceftazidime/avibactam-resistant KPC-Kp BSI.
Keyphrases
  • klebsiella pneumoniae
  • multidrug resistant
  • gram negative
  • escherichia coli
  • risk factors
  • cardiovascular events
  • primary care
  • healthcare
  • coronary artery disease
  • type diabetes
  • health information